ID   CP27A_HUMAN             Reviewed;         531 AA.
AC   Q02318; A8K303; Q6LDB4; Q86YQ6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Sterol 26-hydroxylase, mitochondrial;
DE            EC=1.14.15.15 {ECO:0000250|UniProtKB:P17177};
DE   AltName: Full=5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase;
DE   AltName: Full=Cytochrome P-450C27/25;
DE   AltName: Full=Cytochrome P450 27;
DE   AltName: Full=Sterol 27-hydroxylase;
DE   AltName: Full=Vitamin D(3) 25-hydroxylase;
DE   Flags: Precursor;
GN   Name=CYP27A1; Synonyms=CYP27;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1708392;
RA   Cali J.J., Russell D.W.;
RT   "Characterization of human sterol 27-hydroxylase. A mitochondrial
RT   cytochrome P-450 that catalyzes multiple oxidation reaction in bile
RT   acid biosynthesis.";
RL   J. Biol. Chem. 266:7774-7778(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=7690968; DOI=10.1073/pnas.90.18.8668;
RA   Guo Y.-D., Strugnell S., Back D.W., Jones G.;
RT   "Transfected human liver cytochrome P-450 hydroxylates vitamin D
RT   analogs at different side-chain positions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:8668-8672(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Zhang H.T., Gong Y.;
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15.
RX   PubMed=8514861; DOI=10.1172/JCI116484;
RA   Leitersdorf E., Reshef A., Meiner V., Levitzki R., Schwartz S.P.,
RA   Dann E.J., Berkman N., Cali J.J., Klapholz L., Berginer V.M.;
RT   "Frameshift and splice-junction mutations in the sterol 27-hydroxylase
RT   gene cause cerebrotendinous xanthomatosis in Jews or Moroccan
RT   origin.";
RL   J. Clin. Invest. 91:2488-2496(1993).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   VARIANTS CTX CYS-395 AND CYS-479.
RX   PubMed=2019602;
RA   Cali J.J., Hsieh C.-L., Francke U., Russell D.W.;
RT   "Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase
RT   underlie cerebrotendinous xanthomatosis.";
RL   J. Biol. Chem. 266:7779-7783(1991).
RN   [10]
RP   VARIANTS CTX GLN-474 AND TRP-474.
RX   PubMed=7915755;
RA   Kim K.-K., Kubota S., Kuriyama M., Fujiyama J., Bjorkhem I.,
RA   Eggertsen G., Seyama Y.;
RT   "Identification of new mutations in sterol 27-hydroxylase gene in
RT   Japanese patients with cerebrotendinous xanthomatosis (CTX).";
RL   J. Lipid Res. 35:1031-1039(1994).
RN   [11]
RP   VARIANT CTX GLN-405.
RX   PubMed=9186905;
RA   Chen W., Kubota S., Kim K.-S., Cheng J., Kuriyama M., Eggertsen G.,
RA   Bjorkhem I., Seyama Y.;
RT   "Novel homozygous and compound heterozygous mutations of sterol 27-
RT   hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three
RT   Japanese patients from two unrelated families.";
RL   J. Lipid Res. 38:870-879(1997).
RN   [12]
RP   VARIANT CTX SER-395.
RX   PubMed=9790667; DOI=10.1021/bi9807660;
RA   Chen W., Kubota S., Ujike H., Ishihara T., Seyama Y.;
RT   "A novel arg362ser mutation in the sterol 27-hydroxylase gene (CYP27):
RT   its effects on pre-mRNA splicing and enzyme activity.";
RL   Biochemistry 37:15050-15056(1998).
RN   [13]
RP   VARIANT CTX GLU-145.
RX   PubMed=12000359; DOI=10.1034/j.1399-0004.2002.610303.x;
RA   Lamon-Fava S., Schaefer E.J., Garuti R., Salen G., Calandra S.;
RT   "Two novel mutations in the sterol 27-hydroxylase gene causing
RT   cerebrotendinous xanthomatosis.";
RL   Clin. Genet. 61:185-191(2002).
CC   -!- FUNCTION: Catalyzes the first step in the oxidation of the side
CC       chain of sterol intermediates; the 27-hydroxylation of 5-beta-
CC       cholestane-3-alpha,7-alpha,12-alpha-triol. Has also a vitamin D3-
CC       25-hydroxylase activity. {ECO:0000250|UniProtKB:P17177}.
CC   -!- CATALYTIC ACTIVITY: 5-beta-cholestane-3-alpha,7-alpha,12-alpha-
CC       triol + 6 reduced adrenodoxin + 6 H(+) + 3 O(2) = (25R)-3-alpha,7-
CC       alpha,12-alpha-trihydroxy-5-beta-cholestan-26-oate + 6 oxidized
CC       adrenodoxin + 4 H(2)O. {ECO:0000250|UniProtKB:P17177}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- PATHWAY: Hormone biosynthesis; cholecalciferol biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane.
CC   -!- DISEASE: Cerebrotendinous xanthomatosis (CTX) [MIM:213700]: Rare
CC       sterol storage disorder characterized clinically by progressive
CC       neurologic dysfunction, premature atherosclerosis, and cataracts.
CC       {ECO:0000269|PubMed:12000359, ECO:0000269|PubMed:2019602,
CC       ECO:0000269|PubMed:7915755, ECO:0000269|PubMed:9186905,
CC       ECO:0000269|PubMed:9790667}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M62401; AAA52142.1; -; mRNA.
DR   EMBL; X59812; CAA42481.1; -; mRNA.
DR   EMBL; AY178622; AAO21126.1; -; mRNA.
DR   EMBL; AK290418; BAF83107.1; -; mRNA.
DR   EMBL; CH471063; EAW70654.1; -; Genomic_DNA.
DR   EMBL; BC040430; AAH40430.1; -; mRNA.
DR   EMBL; BC051851; AAH51851.1; -; mRNA.
DR   EMBL; S62709; AAB27199.1; -; Genomic_DNA.
DR   CCDS; CCDS2423.1; -.
DR   PIR; A39740; A39740.
DR   RefSeq; NP_000775.1; NM_000784.3.
DR   UniGene; Hs.516700; -.
DR   PDB; 1MFX; Model; -; A=34-531.
DR   PDBsum; 1MFX; -.
DR   ProteinModelPortal; Q02318; -.
DR   SMR; Q02318; -.
DR   BioGrid; 107965; 6.
DR   IntAct; Q02318; 1.
DR   STRING; 9606.ENSP00000258415; -.
DR   BindingDB; Q02318; -.
DR   ChEMBL; CHEMBL5992; -.
DR   DrugBank; DB06777; Chenodeoxycholic acid.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB06410; Doxercalciferol.
DR   DrugBank; DB00153; Ergocalciferol.
DR   DrugBank; DB00082; Pegvisomant.
DR   GuidetoPHARMACOLOGY; 1369; -.
DR   SwissLipids; SLP:000000142; -.
DR   iPTMnet; Q02318; -.
DR   PhosphoSitePlus; Q02318; -.
DR   BioMuta; CYP27A1; -.
DR   DMDM; 399288; -.
DR   EPD; Q02318; -.
DR   MaxQB; Q02318; -.
DR   PaxDb; Q02318; -.
DR   PeptideAtlas; Q02318; -.
DR   PRIDE; Q02318; -.
DR   Ensembl; ENST00000258415; ENSP00000258415; ENSG00000135929.
DR   GeneID; 1593; -.
DR   KEGG; hsa:1593; -.
DR   UCSC; uc002viz.5; human.
DR   CTD; 1593; -.
DR   DisGeNET; 1593; -.
DR   GeneCards; CYP27A1; -.
DR   GeneReviews; CYP27A1; -.
DR   HGNC; HGNC:2605; CYP27A1.
DR   HPA; HPA059155; -.
DR   MalaCards; CYP27A1; -.
DR   MIM; 213700; phenotype.
DR   MIM; 606530; gene.
DR   neXtProt; NX_Q02318; -.
DR   OpenTargets; ENSG00000135929; -.
DR   Orphanet; 909; Cerebrotendinous xanthomatosis.
DR   PharmGKB; PA135; -.
DR   eggNOG; KOG0159; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000119243; -.
DR   HOGENOM; HOG000253961; -.
DR   HOVERGEN; HBG106909; -.
DR   InParanoid; Q02318; -.
DR   KO; K00488; -.
DR   OMA; EVIDDFM; -.
DR   OrthoDB; EOG091G0MI3; -.
DR   PhylomeDB; Q02318; -.
DR   TreeFam; TF105094; -.
DR   BRENDA; 1.14.99.38; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   UniPathway; UPA00955; -.
DR   ChiTaRS; CYP27A1; human.
DR   GeneWiki; CYP27A1; -.
DR   GenomeRNAi; 1593; -.
DR   PRO; PR:Q02318; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000135929; -.
DR   CleanEx; HS_CYP27A1; -.
DR   ExpressionAtlas; Q02318; baseline and differential.
DR   Genevisible; Q02318; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR   GO; GO:0008395; F:steroid hydroxylase activity; TAS:Reactome.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0016125; P:sterol metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cataract; Complete proteome;
KW   Disease mutation; Heme; Iron; Membrane; Metal-binding; Mitochondrion;
KW   Monooxygenase; NADP; Oxidoreductase; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     33       Mitochondrion.
FT   CHAIN        34    531       Sterol 26-hydroxylase, mitochondrial.
FT                                /FTId=PRO_0000003618.
FT   REGION      384    398       Sterol-binding. {ECO:0000255}.
FT   METAL       476    476       Iron (heme axial ligand).
FT   MOD_RES     283    283       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBG1}.
FT   MOD_RES     509    509       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBG1}.
FT   MOD_RES     520    520       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBG1}.
FT   VARIANT     145    145       G -> E (in CTX; dbSNP:rs72551313).
FT                                {ECO:0000269|PubMed:12000359}.
FT                                /FTId=VAR_016966.
FT   VARIANT     169    169       A -> V (in dbSNP:rs59443548).
FT                                /FTId=VAR_061046.
FT   VARIANT     175    175       T -> M (in dbSNP:rs2229381).
FT                                /FTId=VAR_048467.
FT   VARIANT     395    395       R -> C (in CTX; dbSNP:rs121908096).
FT                                {ECO:0000269|PubMed:2019602}.
FT                                /FTId=VAR_001303.
FT   VARIANT     395    395       R -> S (in CTX; dbSNP:rs121908096).
FT                                {ECO:0000269|PubMed:9790667}.
FT                                /FTId=VAR_012285.
FT   VARIANT     405    405       R -> Q (in CTX; dbSNP:rs121908099).
FT                                {ECO:0000269|PubMed:9186905}.
FT                                /FTId=VAR_012286.
FT   VARIANT     474    474       R -> Q (in CTX; dbSNP:rs121908097).
FT                                {ECO:0000269|PubMed:7915755}.
FT                                /FTId=VAR_012287.
FT   VARIANT     474    474       R -> W (in CTX; dbSNP:rs121908098).
FT                                {ECO:0000269|PubMed:7915755}.
FT                                /FTId=VAR_012288.
FT   VARIANT     479    479       R -> C (in CTX; dbSNP:rs72551322).
FT                                {ECO:0000269|PubMed:2019602}.
FT                                /FTId=VAR_001304.
FT   CONFLICT     20     25       LCPHGA -> SAPTG (in Ref. 2; CAA42481).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       A -> R (in Ref. 2; CAA42481).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       E -> K (in Ref. 3; AAO21126).
FT                                {ECO:0000305}.
SQ   SEQUENCE   531 AA;  60235 MW;  62025EB670DBD8E9 CRC64;
     MAALGCARLR WALRGAGRGL CPHGARAKAA IPAALPSDKA TGAPGAGPGV RRRQRSLEEI
     PRLGQLRFFF QLFVQGYALQ LHQLQVLYKA KYGPMWMSYL GPQMHVNLAS APLLEQVMRQ
     EGKYPVRNDM ELWKEHRDQH DLTYGPFTTE GHHWYQLRQA LNQRLLKPAE AALYTDAFNE
     VIDDFMTRLD QLRAESASGN QVSDMAQLFY YFALEAICYI LFEKRIGCLQ RSIPEDTVTF
     VRSIGLMFQN SLYATFLPKW TRPVLPFWKR YLDGWNAIFS FGKKLIDEKL EDMEAQLQAA
     GPDGIQVSGY LHFLLASGQL SPREAMGSLP ELLMAGVDTT SNTLTWALYH LSKDPEIQEA
     LHEEVVGVVP AGQVPQHKDF AHMPLLKAVL KETLRLYPVV PTNSRIIEKE IEVDGFLFPK
     NTQFVFCHYV VSRDPTAFSE PESFQPHRWL RNSQPATPRI QHPFGSVPFG YGVRACLGRR
     IAELEMQLLL ARLIQKYKVV LAPETGELKS VARIVLVPNK KVGLQFLQRQ C
//
